BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31227779)

  • 1. Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS.
    Knecht H; Reigl T; Kotrová M; Appelt F; Stewart P; Bystry V; Krejci A; Grioni A; Pal K; Stranska K; Plevova K; Rijntjes J; Songia S; Svatoň M; Froňková E; Bartram J; Scheijen B; Herrmann D; García-Sanz R; Hancock J; Moppett J; van Dongen JJM; Cazzaniga G; Davi F; Groenen PJTA; Hummel M; Macintyre EA; Stamatopoulos K; Trka J; Langerak AW; Gonzalez D; Pott C; Brüggemann M; Darzentas N;
    Leukemia; 2019 Sep; 33(9):2254-2265. PubMed ID: 31227779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study.
    Brüggemann M; Kotrová M; Knecht H; Bartram J; Boudjogrha M; Bystry V; Fazio G; Froňková E; Giraud M; Grioni A; Hancock J; Herrmann D; Jiménez C; Krejci A; Moppett J; Reigl T; Salson M; Scheijen B; Schwarz M; Songia S; Svaton M; van Dongen JJM; Villarese P; Wakeman S; Wright G; Cazzaniga G; Davi F; García-Sanz R; Gonzalez D; Groenen PJTA; Hummel M; Macintyre EA; Stamatopoulos K; Pott C; Trka J; Darzentas N; Langerak AW;
    Leukemia; 2019 Sep; 33(9):2241-2253. PubMed ID: 31243313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS.
    Scheijen B; Meijers RWJ; Rijntjes J; van der Klift MY; Möbs M; Steinhilber J; Reigl T; van den Brand M; Kotrová M; Ritter JM; Catherwood MA; Stamatopoulos K; Brüggemann M; Davi F; Darzentas N; Pott C; Fend F; Hummel M; Langerak AW; Groenen PJTA;
    Leukemia; 2019 Sep; 33(9):2227-2240. PubMed ID: 31197258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-Generation Sequencing Technology to Identify Minimal Residual Disease in Lymphoid Malignancies.
    Kotrova M; Darzentas N; Pott C; Brüggemann M;
    Methods Mol Biol; 2021; 2185():95-111. PubMed ID: 33165845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-Generation Sequencing-Based Clonality Detection of Immunoglobulin Gene Rearrangements in B-Cell Lymphoma.
    van Bladel DAG; van der Last-Kempkes JLM; Scheijen B; Groenen PJTA;
    Methods Mol Biol; 2022; 2453():7-42. PubMed ID: 35622318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-Generation Sequencing-Based Clonality Assessment of Ig Gene Rearrangements: A Multicenter Validation Study by EuroClonality-NGS.
    van den Brand M; Rijntjes J; Möbs M; Steinhilber J; van der Klift MY; Heezen KC; Kroeze LI; Reigl T; Porc J; Darzentas N; Luijks JACW; Scheijen B; Davi F; ElDaly H; Liu H; Anagnostopoulos I; Hummel M; Fend F; Langerak AW; Groenen PJTA;
    J Mol Diagn; 2021 Sep; 23(9):1105-1115. PubMed ID: 34186174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocol.
    Svaton M; Skotnicova A; Reznickova L; Rennerova A; Valova T; Kotrova M; van der Velden VHJ; Brüggemann M; Darzentas N; Langerak AW; Zuna J; Stary J; Trka J; Fronkova E
    Blood; 2023 Feb; 141(5):529-533. PubMed ID: 36240445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges.
    Langerak AW; Brüggemann M; Davi F; Darzentas N; van Dongen JJM; Gonzalez D; Cazzaniga G; Giudicelli V; Lefranc MP; Giraud M; Macintyre EA; Hummel M; Pott C; Groenen PJTA; Stamatopoulos K;
    J Immunol; 2017 May; 198(10):3765-3774. PubMed ID: 28416603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARResT/Interrogate Immunoprofiling Platform: Concepts, Workflows, and Insights.
    Darzentas N
    Methods Mol Biol; 2022; 2453():571-584. PubMed ID: 35622342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMGT(®) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS.
    Alamyar E; Duroux P; Lefranc MP; Giudicelli V
    Methods Mol Biol; 2012; 882():569-604. PubMed ID: 22665256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?
    Kotrova M; Trka J; Kneba M; Brüggemann M
    Mol Diagn Ther; 2017 Oct; 21(5):481-492. PubMed ID: 28452038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders.
    Stewart JP; Gazdova J; Darzentas N; Wren D; Proszek P; Fazio G; Songia S; Alcoceba M; Sarasquete ME; Villarese P; van der Klift MY; Heezen KC; McCafferty N; Pal K; Catherwood M; Kim CS; Srivastava S; Kroeze LI; Hodges E; Stamatopoulos K; Klapper W; Genuardi E; Ferrero S; van den Brand M; Cazzaniga G; Davi F; Sutton LA; Garcia-Sanz R; Groenen PJTA; Macintyre EA; Brüggemann M; Pott C; Langerak AW; Gonzalez D;
    Blood Adv; 2021 Aug; 5(16):3188-3198. PubMed ID: 34424321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Clonotypic Rearrangements and Minimal Residual Disease in Lymphoid Malignancies.
    Hussaini MO; Srivastava J; Lee LW; Nishihori T; Shah BD; Alsina M; Pinilla-Ibarz J; Shain KH
    Arch Pathol Lab Med; 2022 Apr; 146(4):485-493. PubMed ID: 34343238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-Step Next-Generation Sequencing of Immunoglobulin and T-Cell Receptor Gene Recombinations for MRD Marker Identification in Acute Lymphoblastic Leukemia.
    Villarese P; Abdo C; Bertrand M; Thonier F; Giraud M; Salson M; Macintyre E
    Methods Mol Biol; 2022; 2453():43-59. PubMed ID: 35622319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of clonal immunoglobulin and T-cell receptor gene recombination in hematological malignancies: monitoring minimal residual disease.
    García-Castillo H; Barros-Núñez P
    Cardiovasc Hematol Disord Drug Targets; 2009 Jun; 9(2):124-35. PubMed ID: 19519371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EuroClonality-NGS Recommendations for Evaluation of B-Cell Clonality Analysis by Next-Generation Sequencing: A Structured Approach with the DEPART Algorithm.
    van den Brand M; Möbs M; Otto F; Kroeze LI; Gonzalez de Castro D; Stamatopoulos K; Davi F; Bravetti C; Kolijn PM; Vlachonikola E; Stewart JP; Pott C; Hummel M; Darzentas N; Langerak AW; Fend F; Groenen PJTA
    J Mol Diagn; 2023 Oct; 25(10):729-739. PubMed ID: 37467928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ClonoSEQ assay for the detection of lymphoid malignancies.
    Monter A; Nomdedéu JF
    Expert Rev Mol Diagn; 2019 Jul; 19(7):571-578. PubMed ID: 31179776
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoglobulin/T-Cell Receptor Gene Rearrangement Analysis Using RNA-Seq.
    van der Velden VHJ; Bastian L; Brüggemann M; Hartmann AM; Darzentas N
    Methods Mol Biol; 2022; 2453():61-77. PubMed ID: 35622320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARResT/Interrogate: an interactive immunoprofiler for IG/TR NGS data.
    Bystry V; Reigl T; Krejci A; Demko M; Hanakova B; Grioni A; Knecht H; Schlitt M; Dreger P; Sellner L; Herrmann D; Pingeon M; Boudjoghra M; Rijntjes J; Pott C; Langerak AW; Groenen PJTA; Davi F; Brüggemann M; Darzentas N;
    Bioinformatics; 2017 Feb; 33(3):435-437. PubMed ID: 28172348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin/T Cell Receptor Capture Strategy for Comprehensive Immunogenetics.
    Stewart JP; Gazdova J; Srivastava S; Revolta J; Harewood L; Maurya M; Darzentas N; Gonzalez D
    Methods Mol Biol; 2022; 2453():133-152. PubMed ID: 35622325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.